Mobiliar took part in a $35m round for medicine transportation system developer SkyCell while Nice Investment co-led wealth management software provider Fount's $33.4m series C.
Funding SkyCell, a Switzerland-based developer of cold-chain pharmaceutical transport systems, received $35m in series C funding yesterday from investors including insurance firm Mobiliar. Investment holding company ADQ’s DisruptAD also took part in the round, as did Shuaa Capital and unnamed family offices, while a Swiss cantonal bank supplied a debt facility of undisclosed size. MVM…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.